Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Nov;50(2):291–297.

Properdin deficiency in a family with fulminant meningococcal infections.

A G Sjöholm, J H Braconier, C Söderström
PMCID: PMC1536695  PMID: 7151327

Abstract

Three males in a large family showed a selective deficiency of properdin (P). One of the P deficient individuals died from a fulminant infection with Neisseria meningitidis group C. The family history revealed three previous cases of similar infections with a fatal outcome. The deficiency did not appear to be associated with repeated bacterial infections. The pattern of inheritance suggested an X-linked mode of transmittance. However, heterozygous carriers were not clearly distinguished in the family. P deficient serum supported immune haemolysis in a normal fashion. Alternative pathway functions, such as the activation of C3 by inulin or zymosan, lysis of guinea-pig erythrocytes in agarose gel and opsonization of endotoxin coated oil particles, were grossly impaired in P deficient serum while efficient C3 activation was produced by addition of cobra venom factor.

Full text

PDF
296

Images in this article

295Fig. 2
on p.295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. Complement deficiency states. Medicine (Baltimore) 1978 Jan;57(1):1–23. doi: 10.1097/00005792-197801000-00001. [DOI] [PubMed] [Google Scholar]
  2. Alper C. A., Colten H. R., Rosen F. S., Rabson A. R., Macnab G. M., Gear J. S. Homozygous deficiency of C3 in a patient with repeated infections. Lancet. 1972 Dec 2;2(7788):1179–1181. doi: 10.1016/s0140-6736(72)92598-6. [DOI] [PubMed] [Google Scholar]
  3. Davis C. A., Forristal J. Partial properdin deficiency. J Lab Clin Med. 1980 Oct;96(4):633–639. [PubMed] [Google Scholar]
  4. Davis C. A., Vallota E. H., Forristal J. Serum complement levels in infancy: age related changes. Pediatr Res. 1979 Sep;13(9):1043–1046. doi: 10.1203/00006450-197909000-00019. [DOI] [PubMed] [Google Scholar]
  5. Fearon D. T., Austen K. F. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection. N Engl J Med. 1980 Jul 31;303(5):259–263. doi: 10.1056/NEJM198007313030505. [DOI] [PubMed] [Google Scholar]
  6. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grubb A. O. Crossed immunoelectrophoresis and electroimmunoassay of IgM. J Immunol. 1974 Apr;112(4):1420–1425. [PubMed] [Google Scholar]
  8. Grubb A. Quantitation of immunoglobulin G by electrophoresis in agarose gel containing antibodies. Scand J Clin Lab Invest. 1970 Nov;26(3):249–255. doi: 10.3109/00365517009046230. [DOI] [PubMed] [Google Scholar]
  9. Götze O., Medicus R. G., Müller-Eberhard H. J. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin. J Immunol. 1977 Feb;118(2):525–532. [PubMed] [Google Scholar]
  10. Laurell A. B., Mårtensson U., Sjöholm A. G. Studies of C1 subcomponents in chronic urticaria and angioedema. Int Arch Allergy Appl Immunol. 1977;54(5):434–442. doi: 10.1159/000231859. [DOI] [PubMed] [Google Scholar]
  11. Martin A., Lachmann P. J., Halbwachs L., Hobart M. J. Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry. 1976 Apr;13(4):317–324. doi: 10.1016/0019-2791(76)90341-4. [DOI] [PubMed] [Google Scholar]
  12. Olofsson T., Odeberg H., Olsson I. Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption, and granule protein composition in isolated granulocytes. Blood. 1976 Oct;48(4):581–593. [PubMed] [Google Scholar]
  13. Petersen B. H., Lee T. J., Snyderman R., Brooks G. F. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med. 1979 Jun;90(6):917–920. doi: 10.7326/0003-4819-90-6-917. [DOI] [PubMed] [Google Scholar]
  14. Robbins J. B. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry. 1978 Nov;15(10-11):839–854. doi: 10.1016/0161-5890(78)90117-7. [DOI] [PubMed] [Google Scholar]
  15. Sjöholm A. G. Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol. 1975;4(1):25–30. doi: 10.1111/j.1365-3083.1975.tb02596.x. [DOI] [PubMed] [Google Scholar]
  16. Snyderman R., Durack D. T., McCarty G. A., Ward F. E., Meadows L. Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med. 1979 Oct;67(4):638–645. doi: 10.1016/0002-9343(79)90247-x. [DOI] [PubMed] [Google Scholar]
  17. Stossel T. P., Alper C. A., Rosen F. S. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide. J Exp Med. 1973 Mar 1;137(3):690–705. doi: 10.1084/jem.137.3.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thompson R. A., Lachmann P. J. A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol. 1977 Jan;27(1):23–29. [PMC free article] [PubMed] [Google Scholar]
  19. Truedsson L., Sjöholm A. G., Laurell A. B. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel. Acta Pathol Microbiol Scand C. 1981 Jun;89(3):161–166. doi: 10.1111/j.1699-0463.1981.tb02680.x. [DOI] [PubMed] [Google Scholar]
  20. Wyatt R. J., Julian B. A., Galla J. H. Properdin deficiency with IgA nephropathy. N Engl J Med. 1981 Oct 29;305(18):1097–1097. doi: 10.1056/NEJM198110293051827. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES